Lisata Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 1.02 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 9.19M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as C...